Biomarkers and precision medicine unit

The Biomarkers and Precision Medicine Unit (BPMU) has a strong interest in the study of the metabolism and the epigenome and their interplay in cancer. At the BPMU, clinicians and basic researchers share the motivation to undertake bench-to-bedside translational research with the goal of promoting precision medicine. Cancer is a very complex disorder that cannot be fully understood only using genetic approaches. In the tumour microenvironment, cells undergo a complex metabolic rewiring for sustaining cell proliferation and growth, two common traits of all cancers.
Dr. Agustín Lahoz Rodriguez

Group leader:

Agustin Lahoz Rodríguez

agustin.lahoz(ELIMINAR)@uv.es

Leader

  • Agustin Lahoz Rodríguez

Emerging Researcher

  • Juan Sandoval Del Amor

Postdoctorals

  • Marta Benet Giménez
  • Juan Carlos Garcia Cañaveras

Predoctorals

  • Maria Isabel Alcoriza Balaguer
  • Elisa Ibañez Martinez

Associated Clinical Collaborators

  • Andrés Briones Gómez
  • José Cerón Navarro
  • Carlos Jorda Aragó
  • Óscar José Juan Vidal
  • Nuria Mancheño Franch

Technician

  • Diana Garcia Latorre
Photo of the research group Biomarkers and precision medicine unit